Quickly analyze and visualize real-world patient data sets to instantly obtain answers to access barriers and prescribing patterns. Patient Access Analytics—from MMIT and Panalgo, both Norstella companies—combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
The Strategic Launch Report—from MMIT, a Norstella company—provides drug manufacturers with a realistic view of payers’ coverage adoption rates and utilization management within the first year post-launch. The report is paired with consensus forecast data from Evaluate, a Norstella company, for currently approved and pipeline agents within the target indication, to help you identify competitors and challenges and proactively plan your near- and long-term strategies.
As integrated delivery networks (IDNs) continue to grow in size and scope, it’s critical that pharma manufacturers target these key accounts, yet finding the right data to inform a robust IDN commercial strategy can seem like an insurmountable obstacle. PULSE Analytics from MMIT and The Dedham Group—both Norstella companies—provides one of the most comprehensive and granular data sets to help pharma companies get the actionable insights they need to target these critical accounts.
We're looking for agile, growth-oriented team players who are passionate about client success and helping patients get access to the therapies they need.Work with us
Have questions about Norstella or its brands? Or do you want to know more about how to solve your market access challenges?We want to hear from you